Lipid and pleiotropic effects of atorvastatin in patients with high cardiovascular risk

Aim. To study the safety, lipid-lowering effectiveness, and anti-inflammatory activity of three-month therapy with generic atorvastatin (Atomax) in patients with high cardiovascular risk and dyslipidemia (DLP).Material and methods. The study included 36 DLP patients: Group I (n=17) with coronary hea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: R. S. Karpov, O. A. Koshelskaya, A. S. Sushkova
Formato: Artigo
Idioma:Russo
Publicado em: «SILICEA-POLIGRAF» LLC 2009-08-01
Colecção:Кардиоваскулярная терапия и профилактика
Assuntos:
atorvastatin
high cardiovascular risk
coronary heart disease
diabetes mellitus
dyslipidemia
c-reactive protein
pro-inflammatory cytokines
Acesso em linha:https://cardiovascular.elpub.ru/jour/article/view/1358
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados